Skip to main content

Von Willebrand Diseases clinical trials at UCSF
1 research study open to eligible people

  • Clinical Performance Evaluation of T-TAS 01 PL Chip

    open to eligible people ages 21 years and up

    This study will measure primary hemostatic ability using the T-TAS 01 System with PL chip, with a comparison to clinical truth.

    San Francisco, California and other locations

Last updated: